Short-chain fructo-oligosaccharide administration dose-dependently increases fecal bifidobacteria in healthy humans.
about
Adaptation to Lactose in Lactase Non Persistent People: Effects on Intolerance and the Relationship between Dairy Food Consumption and Evalution of DiseasesFiber and prebiotic supplementation in enteral nutrition: A systematic review and meta-analysisFour-week short chain fructo-oligosaccharides ingestion leads to increasing fecal bifidobacteria and cholesterol excretion in healthy elderly volunteers.Digestive tolerance and postprandial glycaemic and insulinaemic responses after consumption of dairy desserts containing maltitol and fructo-oligosaccharides in adults.Dietary fiber in irritable bowel syndrome (Review)Dietary fiber and prebiotics and the gastrointestinal microbiotaTranscription of two adjacent carbohydrate utilization gene clusters in Bifidobacterium breve UCC2003 is controlled by LacI- and repressor open reading frame kinase (ROK)-type regulatorsTolerability and safety of the intake of bovine milk oligosaccharides extracted from cheese whey in healthy human adultsFermentation of fructooligosaccharides and inulin by bifidobacteria: a comparative study of pure and fecal culturesThe capacity of short-chain fructo-oligosaccharides to stimulate faecal bifidobacteria: a dose-response relationship study in healthy humans.Nutritionally improved agricultural crops.Galacto-oligosaccharides and Colorectal Cancer: Feeding our Intestinal ProbiomeEffect of an α-lactalbumin-enriched infant formula supplemented with oligofructose on fecal microbiota, stool characteristics, and hydration status: a randomized, double-blind, controlled trialPhylum level change in the cecal and fecal gut communities of rats fed diets containing different fermentable substrates supports a role for nitrogen as a factor contributing to community structure.Identification of prebiotic fructooligosaccharide metabolism in Lactobacillus plantarum WCFS1 through microarraysTolerance and the effect of high doses of wheat bran extract, containing arabinoxylan-oligosaccharides, and oligofructose on faecal output: a double-blind, randomised, placebo-controlled, cross-over trialDevelopment of functional canned and pouched tuna products added inulin for commercial production.Influence of fructooligosaccharide on pharmacokinetics of isoflavones in postmenopausal womenAn Alteration in the Cecal Microbiota Composition by Feeding of 1-Kestose Results in a Marked Increase in the Cecal Butyrate Content in Rats.In vitro degradation and fermentation of three dietary fiber sources by human colonic bacteria.Polydextrose, lactitol, and fructo-oligosaccharide fermentation by colonic bacteria in a three-stage continuous culture system.Low level of galacto-oligosaccharide in infant formula stimulates growth of intestinal Bifidobacteria and Lactobacilli.Dietary Fiber and the Human Gut Microbiota: Application of Evidence Mapping Methodology.Metabolism of fructooligosaccharides by Lactobacillus paracasei 1195.In situ production of exopolysaccharides during Sourdough fermentation by cereal and intestinal isolates of lactic acid bacteria.Dietary fructooligosaccharides up-regulate immunoglobulin A response and polymeric immunoglobulin receptor expression in intestines of infant mice.Moderately high-protein enteral formula improved retinol-binding protein in tube-fed patients: A multicentre open study.A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies.Exposure of Intestinal Epithelial Cells to Short- and Long-Chain Fructo-Oligosaccharides and CpG Oligodeoxynucleotides Enhances Peanut-Specific T Helper 1 Polarization.
P2860
Q26796616-E585B960-E85F-4CE1-A7F9-4E7C2086D530Q28084743-ACFB8132-F674-4042-AB8D-0A8C44AC746CQ33438678-CFA552C2-B290-4E5D-A213-C8249E901671Q33461093-2C669964-09B9-4D3B-B28C-6502411E7DA6Q33470938-06041CAB-02A9-4AAE-841F-0983E8F255BAQ33562095-A9126C33-7A39-4C45-B6D7-D6E08D3A3716Q33743073-688565DE-E82F-4AB0-BAC5-0FC3D012DAB1Q33782411-629DBDF7-0389-4CCD-9AB2-4D49377D70E4Q34097784-6736F848-CE97-48D7-A5FB-CC0C942A0736Q34567483-672F44E6-F0EC-4E95-B82C-7C9610DCD8BEQ34593952-AFD2E22C-72D4-4A34-B717-9D7D59081ED3Q34881370-9ED92D4D-64D3-4212-A320-69170E0F600BQ35209893-5E39CA74-052F-47B0-8B8F-0DC90EE4690CQ35625092-EB53BE6F-AF46-4509-B066-ABD6BDF4142BQ35689997-A072B388-E850-4687-89F8-3FC965EF3DF7Q35757434-F1D5972C-24EE-46DE-9E4C-F081B11CB5B8Q35901296-639BD953-CD47-4A4D-80B3-1579D1CEB7BBQ35955164-4704D25B-032F-4021-8AF2-3FB5A736EF4CQ36197635-5B38A914-975A-4876-81F3-2A474021DE91Q36890776-A26C1B24-AC9D-42EC-8882-C6CCA60B2F00Q37043318-0B2E3352-C1B7-4F5A-8246-B5C1E013BED0Q37411960-19B0AF1F-06A8-4D6E-BCAE-B12814904A50Q37673181-BF79F350-A9A6-4306-9B6C-FEE35666933DQ38355903-F232F33E-9FD0-48F1-B8F4-919050E783A8Q39708415-D7695C2A-3D27-4D35-A95A-83F4366C5C0FQ47346652-03D053E9-B52A-4B88-9657-D4DDC8CC9FBEQ47773562-4BC7C5CE-35B6-4B0E-864F-986C3B3B94C7Q54263480-76AF5E7D-ADFF-4607-AB28-79E3208C9FA1Q55313405-52358F14-EA14-403C-B289-6A8DED0B7037
P2860
Short-chain fructo-oligosaccharide administration dose-dependently increases fecal bifidobacteria in healthy humans.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Short-chain fructo-oligosaccha ...... idobacteria in healthy humans.
@ast
Short-chain fructo-oligosaccha ...... idobacteria in healthy humans.
@en
Short-chain fructo-oligosaccha ...... idobacteria in healthy humans.
@nl
type
label
Short-chain fructo-oligosaccha ...... idobacteria in healthy humans.
@ast
Short-chain fructo-oligosaccha ...... idobacteria in healthy humans.
@en
Short-chain fructo-oligosaccha ...... idobacteria in healthy humans.
@nl
prefLabel
Short-chain fructo-oligosaccha ...... idobacteria in healthy humans.
@ast
Short-chain fructo-oligosaccha ...... idobacteria in healthy humans.
@en
Short-chain fructo-oligosaccha ...... idobacteria in healthy humans.
@nl
P2093
P356
P1433
P1476
Short-chain fructo-oligosaccha ...... fidobacteria in healthy humans
@en
P2093
J C Rambaud
P304
P356
10.1093/JN/129.1.113
P407
P577
1999-01-01T00:00:00Z